| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |